Rome Therapeutics Raises $77M Series B
Biotech startup, Rome Therapeutics, Raises $77M Series B
Venture Beyond
Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies.
Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines.
We invest across the entirety of technology and healthcare. This includes software, cybersecurity, advanced communications and computation, space, climate change related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics and more.
Cumulative Team Experience
0
Exits
0
$1B Valuations
$1B+
AUM
People & Talent
Our portfolio companies have access to top experts as they build, scale, and optimize their teams. We help in-house teams source hard-to-find talent and advise executive teams and boards on a range of people issues, from culture and compensation philosophy to crisis management.
Data
Operations
The team that runs our day-to-day firm operations. We lend expertise to portfolio companies where applicable.
Portfolio
* Exit
News
